{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:22:43Z","timestamp":1790738563327,"version":"4.1.0"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>The aim was to analyze the role of Epstein-Barr virus (EBV) in the bioclinical characteristics of patients treated for classic Hodgkin lymphoma (cHL) in France.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Biopathologic data of 301 patients treated for a cHL in\/or according to the EuroNet PHL-C1 trial between November 2008 and February 2013 were centrally reviewed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Median age at diagnosis was 14 (3 to 18) years and the F\/M ratio 0.86, 0.47 before 10 years and 0.9 from 11 to 18. CHL subtypes were nodular sclerosis for 266\/301 (88%) patients, mixed cellularity for 22\/301 (7%), lymphocyte rich for 2\/301 (1%), and 11\/301 were unclassified. EBV positivity by in situ hybridization was observed for 68\/301 (23%) patients, significantly associated with mixed cellularity subtype and male sex, particularly overrepresented in boys below 10 years: 15\/23 (65%) versus 28\/139 among other male patients (20%). EBV viral load was detectable in 22 of 108 (22%) tested cases and was overrepresented in EBV cHL (13\/28) versus non-EBV cHL (9\/80) patients. Detailed semiquantitative histologic analysis showed a high number of B-cell residual follicles in EBV cHL relative to EBV-negative HL.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Distribution of EBV cHL in children and adolescents is associated with young age and male sex, suggesting a specific physiopathology and may require a differential therapeutic approach.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mph.0000000000002403","type":"journal-article","created":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T21:44:15Z","timestamp":1643406255000},"page":"e1033-e1038","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Epstein-Barr Virus in Childhood and Adolescent Classic Hodgkin Lymphoma in a French Cohort of 301 Patients"],"prefix":"10.1097","volume":"44","author":[{"given":"Victor","family":"Pereira","sequence":"first","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Besan\u00e7on University Hospital, Besan\u00e7on"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabah","family":"Boudjemaa","sequence":"additional","affiliation":[{"name":"Departments of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Besson","sequence":"additional","affiliation":[{"name":"Department of Hematology Versailles University Hospital, Versailles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Leblanc","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Immunology, APHP, Robert Debr\u00e9 Hospital"},{"name":"Paris Diderot University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Rigaud","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Gustave Roussy Cancer Campus, Villejuif"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaury","family":"Leruste","sequence":"additional","affiliation":[{"name":"SIREDO, Pediatric Cancer Center, Institut Curie, PSL Research University, Paris"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Garnier","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Pediatric Hematology and Oncology Institute, Hospices Civils de Lyon, Lyon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Lambilliotte","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Lille University Hospital, Lille"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Simonin","sequence":"additional","affiliation":[{"name":"Pediatric Hematology and Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Curtillet","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, APHM, La Timone Hospital, Marseille"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacinthe","family":"Bonneau-Lagacherie","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Rennes University Hospital, Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Coulomb","sequence":"additional","affiliation":[{"name":"Pathology, APHP, Armand Trousseau Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Landman-Parker","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Armand Trousseau Hospital, APHP, Sorbonne University, UMRs938"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,1,28]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/PPO.0b013e31819e31cf","article-title":"Histopathology of Hodgkin\u2019s lymphoma","volume":"15","author":"Eberle","year":"2009","journal-title":"Cancer J"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"R4-20250804","first-page":"321","article-title":"Epidemiologic studies assessing the role of the Epstein-Barr virus in Hodgkin\u2019s disease","volume":"60","author":"Mueller","year":"1987","journal-title":"Yale J Biol Med"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ijc.2910340203","article-title":"A population-based case-control study of EBV and other viral antibodies among persons with Hodgkin\u2019s disease and their siblings","volume":"34","author":"Evans","year":"1984","journal-title":"Int J Cancer"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/0046-8177(93)90008-5","article-title":"Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphomas arising in patients without overt pre-existing immunodeficiency","volume":"24","author":"Kanavaros","year":"1993","journal-title":"Hum Pathol"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/jcp.48.9.845","article-title":"Down-regulation of Epstein-Barr virus nuclear antigen 1 in Reed-Sternberg cells of Hodgkin\u2019s disease","volume":"48","author":"Khan","year":"1995","journal-title":"J Clin Pathol"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/adc.74.1.27","article-title":"The role of Epstein-Barr virus in Hodgkin\u2019s disease from different geographical areas","volume":"74","author":"Weinreb","year":"1996","journal-title":"Arch Dis Child"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1093\/annonc\/7.suppl_4.S5","article-title":"Epidemiology of EBV and Hodgkin\u2019s lymphoma","volume":"7","author":"Jarrett","year":"1996","journal-title":"Ann Oncol"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"181","DOI":"10.11604\/pamj.2018.29.181.11847","article-title":"Evidence of EBV infection in lymphomas diagnosed in Lusaka, Zambia","volume":"29","author":"Kafita","year":"2018","journal-title":"Pan Afr Med J"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood.2019000568","article-title":"An etiological role for the Epstein-Barr virus in the pathogenesis of classical Hodgkin lymphoma","volume":"134","author":"Murray","year":"2019","journal-title":"Blood"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"801","DOI":"10.4269\/ajtmh.1998.59.801","article-title":"A comparison of epidemiologic, histologic, and virologic studies on Hodgkin\u2019s disease in western Kenya and Nagasaki, Japan","volume":"59","author":"Toriyama","year":"1998","journal-title":"Am J Trop Med Hygiene"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/hon.984","article-title":"Disease patterns in pediatric classical Hodgkin lymphoma: a report from a developing area in Brazil","volume":"29","author":"Barros","year":"2011","journal-title":"Hematologic Oncol"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"e12120","DOI":"10.1097\/MD.0000000000012120","article-title":"Epidemiologic characteristics of malignant lymphoma in Hubei, China: a single-center 5-year retrospective study","volume":"97","author":"Meng","year":"2018","journal-title":"Medicine"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"e21152","DOI":"10.1371\/journal.pone.0021152","article-title":"Epidemiology of classical Hodgkin lymphoma and its association with Epstein Barr virus in Northern China","volume":"6","author":"Huang","year":"2011","journal-title":"PLoS One"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.hemonc.2013.12.002","article-title":"Epstein\u2013Barr virus and Hodgkin lymphoma in Jordan","volume":"7","author":"Sughayer","year":"2014","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"R17-20250804","first-page":"709","article-title":"Hodgkin lymphoma incidence in California Hispanics: influence of nativity and tumor Epstein\u2013Barr virus","volume":"25","author":"Glaser","year":"2014","journal-title":"Cancer Causes Control"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3816\/CLM.2009.n.042","article-title":"Hodgkin lymphoma: an update on its biology with new insights into classification","volume":"9","author":"Mani","year":"2009","journal-title":"Clin Lymph Myel"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/MPH.0b013e3181647bc3","article-title":"Pediatric Hodgkin lymphoma in 2 South American series: a distinctive epidemiologic pattern and lack of association of Epstein-Barr virus with clinical outcome","volume":"30","author":"Chabay","year":"2008","journal-title":"J Pediatr Hematol Oncol"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.arcmed.2014.06.001","article-title":"Prevalence and prognostic significance of Epstein\u2013Barr virus infection in classical Hodgkin\u2019s lymphoma: a meta-analysis","volume":"45","author":"Lee","year":"2014","journal-title":"Arch Med Res"},{"key":"R21-20250804","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/pin.12175","article-title":"Prognostic significance of CD20 expression and Epstein-Barr virus (EBV) association in classical Hodgkin lymphoma in Japan: a clinicopathologic study: CD20 expression & EBV association in CHL","volume":"64","author":"Elsayed","year":"2014","journal-title":"Pathol Int"},{"key":"R22-20250804","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ejca.2006.10.008","article-title":"Time trends in the registration of Hodgkin and non-Hodgkin lymphomas in Europe","volume":"43","author":"Adamson","year":"2007","journal-title":"Eur J Cancer"},{"key":"R23-20250804","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1080\/10428190701411177","article-title":"Association between Epstein-Barr virus and Hodgkin\u2019s lymphoma in Belgium: a pathological and virological study","volume":"48","author":"Trim\u00e8che","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"R24-20250804","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1200\/JCO.2008.20.5138","article-title":"Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin\u2019s lymphoma predicts adverse outcome in older adult patients","volume":"27","author":"Diepstra","year":"2009","journal-title":"JCO"},{"key":"R25-20250804","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","article-title":"Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin\u2019s disease: Cotswolds meeting","volume":"7","author":"Lister","year":"1989","journal-title":"JCO"},{"key":"R26-20250804","first-page":"1","article-title":"Frequent altered distribution of peripheral B-lymphocyte subsets in pediatric and adolescent patients with classical Hodgkin lymphoma","volume":"62","author":"Hamdi","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"R27-20250804","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1136\/jcp.56.11.811","article-title":"The Scotland and Newcastle epidemiological study of Hodgkin\u2019s disease: impact of histopathological review and EBV status on incidence estimates","volume":"56","author":"Jarrett","year":"2003","journal-title":"J Clin Pathol"},{"key":"R28-20250804","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/(SICI)1097-0215(19970207)70:4<375::AID-IJC1>3.0.CO;2-T","article-title":"Epstein-Barr virus-associated Hodgkin\u2019s disease: epidemiologic characteristics in international data","volume":"70","author":"Glaser","year":"1997","journal-title":"Int J Cancer"},{"key":"R29-20250804","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejca.2006.08.036","article-title":"Hodgkin\u2019s lymphoma in Indian children: prevalence and significance of Epstein\u2013Barr virus detection in Hodgkin\u2019s and Reed\u2013Sternberg cells","volume":"43","author":"Dinand","year":"2007","journal-title":"Eur J Cancer"},{"key":"R30-20250804","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/08880018.2014.954071","article-title":"Pediatric Hodgkin lymphoma in a South Indian Regional Cancer Center: its immunomorphology, tumor-associated macrophages, and association with Epstein\u2013Barr virus","volume":"32","author":"Zameer","year":"2015","journal-title":"Pediatr Hematol Oncol"},{"key":"R31-20250804","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1046\/j.1365-2141.2001.02767.x","article-title":"Marked decrease in the Epstein-Barr virus positivity rate in nodular sclerosis subtype Hodgkin\u2019s disease in Tokyo: trend between 1955 and 1999","volume":"113","author":"Takeuchi","year":"2001","journal-title":"Br J Haematol"},{"key":"R32-20250804","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1038\/s41598-018-20133-6","article-title":"Frequency of EBV associated classical Hodgkin lymphoma decreases over a 54-year period in a Brazilian population","volume":"8","author":"Campos","year":"2018","journal-title":"Sci Rep"},{"key":"R33-20250804","doi-asserted-by":"crossref","first-page":"20160271","DOI":"10.1098\/rstb.2016.0271","article-title":"Epstein\u2013Barr virus-associated lymphomas","volume":"372","author":"Shannon-Lowe","year":"2017","journal-title":"Phil Trans R Soc B"},{"key":"R34-20250804","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.ejca.2006.05.012","article-title":"Hodgkin\u2019s disease incidence and survival in European children and adolescents (1978\u20131997): Report from the Automated Cancer Information System project","volume":"42","author":"Clavel","year":"2006","journal-title":"Eur J Cancer"},{"key":"R35-20250804","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa023141","article-title":"Characteristics of Hodgkin\u2019s lymphoma after infectious mononucleosis","volume":"349","author":"Hjalgrim","year":"2003","journal-title":"N Engl J Med"},{"key":"R36-20250804","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1158\/0008-5472.CAN-06-3566","article-title":"Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma","volume":"67","author":"Hjalgrim","year":"2007","journal-title":"Cancer Res"},{"key":"R37-20250804","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1158\/1055-9965.EPI-15-0281","article-title":"Time trends in rates of Hodgkin lymphoma histologic subtypes: true incidence changes or evolving diagnostic practice?","volume":"24","author":"Glaser","year":"2015","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"R38-20250804","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1097\/CEJ.0000000000000383","article-title":"Incidence and survival of Hodgkin lymphoma patients in Girona (Spain) over three decades: a population-based study","volume":"26","author":"Solans","year":"2017","journal-title":"Eur J Cancer Prev"},{"key":"R39-20250804","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1054\/bjoc.2001.1774","article-title":"Assessment of the prognostic impact of the Epstein\u2013Barr virus-encoded latent membrane protein-1 expression in Hodgkin\u2019s disease","volume":"84","author":"Glavina-Durdov","year":"2001","journal-title":"Br J Cancer"},{"key":"R40-20250804","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000093639","article-title":"Association between the Epstein-Barr virus and Hodgkin\u2019s lymphoma in the North-Eastern part of hungary: effects on therapy and survival","volume":"116","author":"Keresztes","year":"2006","journal-title":"Acta Haematol"},{"key":"R41-20250804","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1146\/annurev.immunol.16.1.471","article-title":"The origin of Hodgkin and Reed\/Sternberg cells in Hodgkin\u2019s disease","volume":"16","author":"K\u00fcppers","year":"1998","journal-title":"Annu Rev Immunol"},{"key":"R42-20250804","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1182\/blood-2018-02-833806","article-title":"Are EBV-related and EBV-unrelated Hodgkin lymphomas different with regard to susceptibility to checkpoint blockade?","volume":"132","author":"Carbone","year":"2018","journal-title":"Blood"},{"key":"R43-20250804","doi-asserted-by":"crossref","first-page":"e27757","DOI":"10.1002\/pbc.27757","article-title":"PD-L1 expression in pediatric Epstein-Barr virus positive classic Hodgkin lymphoma is not associated with 9p24.1 amplification","volume":"66","author":"Uccini","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"R44-20250804","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1158\/1078-0432.CCR-11-1942","article-title":"Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy","volume":"18","author":"Green","year":"2012","journal-title":"Clin Cancer Res"},{"key":"R45-20250804","first-page":"270","article-title":"Interim results from a phase 1 study of ADCT- 301 (camidanlumab tesirine) show promising activity of a novel pyrrolobenzodiazepine- based antibody drug conjugate in relapsed\/refractory Hodgkin\/non-Hodgkin lymphoma","volume":"35","author":"Fanale","year":"2017","journal-title":"Blood"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002403","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:02:37Z","timestamp":1754337757000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,28]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002403","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,28]]},"assertion":[{"value":"2021-08-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}